My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
IVRCL declines after poor Q2 numbers
Dec 15,2016

The result was announced after market hours yesterday, 14 December 2016.

Meanwhile, the S&P BSE Sensex was down 29.14 points or 0.11% at 26,573.70.

On the BSE, 1.30 lakh shares were traded on the counter so far as against the average daily volumes of 4.49 lakh shares in the past two weeks. The stock had hit a high of Rs 4.80 and a low of Rs 4.61 so far during the day.

The companys total income from operations declined 21.77% to Rs 501.45 crore in Q2 September 2016 over Q2 September 2015.

IVRCL is a leading engineering, procurement and construction (EPC) and infrastructure company. Its core areas of work include value chain across sectors such as water & environment, irrigation, transportation and power distribution & transmission.

Powered by Capital Market - Live News

Unitech slips after reporting disappointing Q2 results
Dec 15,2016

The result was announced after market hours yesterday, 14 December 2016.

Meanwhile, the BSE Sensex was down 69.91 points, or 0.26%, to 26,530.78.

On the BSE, 20.41 lakh shares were traded in the counter so far, compared with an average volume of 38.07 crore shares in the past one quarter. The stock had hit a high of Rs 4.74 and a low of Rs 4.57 so far during the day. The stock had hit a 52-week low of Rs 3.43 on 11 February 2016. The stock had hit a 52-week high of Rs 9.05 on 18 July 2016.

The stock had underperformed the market over the past one month till 14 December 2016, falling 9.21% compared with the Sensexs 0.81% fall. The scrip had also underperformed the market in past one quarter, declining 22.33% as against the Sensexs 6.24% fall.

The small-cap company has an equity capital of Rs 523.26 crore. Face value per share is Rs 2.

Unitechs total income dropped 42.27% to Rs 385.94 crore in Q2 September 2016 over Q2 September 2015.

Unitech is one of Indias leading real estate player. It has a diversified product mix in real estate comprising of commercial complexes, IT/ITes parks, special economic zones (SEZs), integrated residential developments, schools, hotels, malls, golf courses and amusement parks.

Powered by Capital Market - Live News

Tata Comm gains after announcing pact with Hitachi Sunway
Dec 15,2016

The announcement was made during market hours today, 15 December 2016.

Meanwhile, the S&P BSE Senses was down 42.51 points or 0.16% at 26,560.33.

On the BSE, 47,000 shares were traded on the counter as against the average daily volumes of 41,000 shares in the past two weeks. The stock had hit a high of Rs 632.20 and a low of Rs 618 so far during the day.

Hitachi Sunway Information Systems Sdn. Bhd (Hitachi Sunway), a leading one-stop IT services and solutions provider in ASEAN, announced a partnership with Tata Communications. With this partnership, Hitachi Sunway will now be able to provide its more than 1,000 enterprise customers in ASEAN access to Tata Communications robust portfolio of managed network services, managed security services and unified communications & collaboration (UCC) offerings.

Sumeet Walia, Head, Global Enterprise Business, Tata Communications said that in the past year, Tata Communications has continued to invest in a broad range of service expansions, introducing new advanced managed services built on its strong network presence in the emerging and developed markets. The companys strategic partnerships are a key component of this strategy as it delivers dedicated platforms that enable business transformation for enterprises across the globe. Hitachi Sunways regional presence and credibility were the reason the company picked them as its partner here in ASEAN. Tata Communications is pleased to be working with them to expand its footprint in the region, Walia said.

Tata Communications owns and operates the worlds largest and most advanced subsea fibre cable network. Today over 24% of the worlds Internet routes travel over Tata Communications network, and the company is the only Tier-1 provider that is in the top five by routes in five continents.

Powered by Capital Market - Live News

Yes Bank edges higher after partnering with FT42 Labs for cyber security solution
Dec 15,2016

The announcement was made during market hours today, 15 December 2016.

Meanwhile, the BSE Sensex was down 30.58 points, or 0.04%, to 26,592.34.

On the BSE, 49,809 shares were traded in the counter so far, compared with average daily volume of 2.85 lakh shares in the past one quarter. The stock had hit a high of Rs 1,204.50 and a low of Rs 1,180 so far during the day.

Yes Bank said that the partnership is for developing next generation Fintech and cyber security solutions. One of the first innovations, the PI-CONTROL platform that the bank has jointly developed with FortyTwo42 Labs will be rolled out in the next few weeks. The solution has the capability to provide real time cryptographic digital transaction signing at massive scale.

FortyTwo42 Labs has a set up in Vizag and Pune in India and Tel Aviv in Israel.

Yes Bank reported 31.3% rise in net profit to Rs 801.54 crore on 24.7% rise in total income to Rs 4982.23 crore in Q2 September 2016 over Q2 September 2015.

Yes Bank is one of the leading private sector banks in India.

Powered by Capital Market - Live News

Titagarh Wagons moves ahead after reporting turnaround in Q2
Dec 15,2016

The result was announced after market hours yesterday, 14 December 2016.

Meanwhile, the BSE Sensex was up 101.62 points, or 0.38%, to 26,694.47.

On the BSE, so far 69,532 shares were traded in the counter, compared with average daily volumes of 1.49 lakh shares in the past one quarter. The stock had hit a high of Rs 118.05 and a low of Rs 115.10 so far during the day.

Titagarh Wagons net total income from operations rose 19.53% to Rs 103.82 crore in Q2 September 2016 over Q2 September 2015.

Titagarh Wagons designs and manufactures wagons such as container flats, grain hoppers, cement wagons, clinker wagons, tank wagon under the French brand Arbel Fauvet Rail. Titagarh also manufacturers cast steel bogies and couplers for freight application.

Powered by Capital Market - Live News

Cimmco advances after trimming losses in Q2
Dec 15,2016

The result was announced after market hours yesterday, 14 December 2016.

Meanwhile, the S&P BSE Sensex was up 123.11 points or 0.46% at 26,725.95.

On the BSE, 1,360 shares were traded in the counter so far as against average daily volume of 10,589 shares in the past one quarter. The stock had hit a high of Rs 68.55 and a low of Rs 65.55 so far during the day.

The small-cap company has equity capital of Rs 20.15 crore. Face value per share is Rs 10.

Cimmcos net total income from operations jumped 519% to Rs 43.70 crore in Q2 September 2016 over Q2 September 2015.

Cimmco is engaged in the manufacturing and selling of railway wagons and heavy engineering products.

Powered by Capital Market - Live News

Infosys firms up after making investment in startup providing UAV solutions
Dec 15,2016

The announcement was made after market hours yesterday, 14 December 2016.

Meanwhile, the S&P BSE Sensex was up 99.08 points or 0.37% at 26,701.92.

On the BSE, 74,325 shares were traded in the counter so far as against average daily volume of 1.42 lakh shares in the past one quarter. The stock had hit high of Rs 1,018.90 and low of Rs 993.50 so far during the day.

IdeaForges high performance Unmanned Aerial Vehicle (UAV), which have been designed and built in India, have significant potential in industrial use cases.

The investment is subject to receipt of regulatory approvals and customary closing conditions.

Infosys consolidated net profit rose 4.9% to Rs 3606 crore on 3.1% growth in revenue to Rs 17310 crore in Q2 September 2016 over Q1 June 2016.

Infosys is one of the leading information technology outsourcing services providers. The company provides business consulting, information technology and outsourcing services.

Powered by Capital Market - Live News

Cipla gains after subsidiary forms a pharma joint venture in Iran
Dec 15,2016

The announcement was made after market hours yesterday, 14 December 2016.

Meanwhile, the S&P BSE Sensex was up 97.89 points or 0.37% at 26,700.73.

On the BSE, 18,438 shares were traded in the counter so far as against average daily volume of 1.42 lakh shares in one quarter. The stock had hit a high of Rs 576.20 and a low of Rs 569 so far during the day. The stock had hit a 52-week high of Rs 660 on 29 December 2015. The stock had hit a 52-week low of Rs 458.25 on 25 May 2016.

The stock had outperformed the market over the past one month till 14 December 2016, gaining 3.41% compared with the Sensexs 0.81% fall. The scrip had also outperformed the market in past one quarter, declining 1.42% as against the Sensexs 6.24% fall.

The large-cap company has equity capital of Rs 160.85 crore. Face value per share is Rs 2.

Cipla announced that Cipla Holding B.V., a wholly owned subsidiary of the company in Netherlands, Cipla Netherlands, has entered into a joint venture agreement with its joint venture partner, Ahran Tejarat Company.

Cipla Netherlands will hold a 75% stake in a joint venture company in Iran while Ahran Tejarat will hold the remaining 25% stake. The expected investment by Cipla Netherlands is estimated to be a maximum of Euro 16.875 million.

The joint venture company proposes to undertake manufacturing and marketing of pharmaceutical products in Iran.

As part of the transaction, Issat Company, an existing company in Iran incorporated on 19 January 1998 and currently owned by Ahran Tejarat, is proposed to be used as the JV company for the purposes of the transaction.

Issat Company has a valid pharmaceutical manufacturing license in Iran and also owns certain fixed asset but has not undertaken any business activity since incorporation and as a result does not currently have any turnover.

Cipla Netherlands will initially acquire a 75% stake in Issat Company from the JV partner for a consideration of Euro 1.35 million payable in cash and the balance amount of upto Euro 15.52 million is expected to be infused by Cipla Netherlands into Issat Company as equity over next one year period.

The acquisition is expected to be completed by March 2017, subject to completion of conditions precedent and applicable regulatory approvals.

Separately, Cipla announced that a meeting of the board of directors of the company is scheduled to be held on 19 December 2016, to consider the proposal of raising funds through issue of equity shares or American depository receipts or global depository receipts or foreign currency convertible bonds or non-convertible debentures- in the form of bonds or otherwise or bonds or any other securities/financial instruments, whether denominated in Indian Rupee and/or foreign currency(ies), either by way of a public issue or by way of a private placement, including through a qualified institutions placement in accordance with the provisions of the applicable law.

The fund raising would be subject to necessary permissions, sanctions and approvals, including shareholders approval and such other statutory approvals as may be required and the provisions of the laws.

On a consolidated basis, Ciplas net profit dropped 34.7% to Rs 354.34 crore on 8.7% rise in net sales to Rs 3671.88 crore in Q2 September 2016 over Q2 September 2015.

Cipla is a global pharmaceutical company.

Powered by Capital Market - Live News

Axis Bank climbs up after board approves allotment of debentures
Dec 15,2016

The announcement was made after market hours yesterday, 14 December 2016.

Meanwhile, the BSE Sensex was down 60.39 points, or 0.23%, to 26,542.45.

On the BSE, 31,213 shares were traded in the counter so far, compared with average daily volume of 7.15 lakh shares in the past one quarter. The stock had hit a high of Rs 469.50 and a low of Rs 456.10 so far during the day.

Axis Bank said that the board of directors approved the allotment of 35,000 unsecured, subordinated, perpetual additional tier 1, Basel III compliant non convertible debentures (Series - 26) of face value of Rs 10 lakh each aggregating Rs 3500 crore on private placement basis.

Axis Banks net profit declined 83.3% to Rs 319.08 crore on 14.1% growth in total income to Rs 13698.77 crore in Q2 September 2016 over Q2 September 2015.

Axis Bank is one of the biggest private sector banks in India.

Powered by Capital Market - Live News

Sunteck Realty corrects on profit booking
Dec 14,2016

Meanwhile, the BSE Sensex was down 82.06 points, or 0.31%, to 26,615.76.

On the BSE, so far 2.25 lakh shares were traded in the counter, compared with average daily volumes of 35,770 shares in the past one quarter. The stock had hit a high of Rs 230.40 and a low of Rs 219 so far during the day.

The stock hit a 52-week high of Rs 300 on 30 October 2016. The stock hit a 52-week low of Rs 173 on 12 February 2016. The stock had outperformed the market over the past 30 days till 13 December 2016, rising 6.18% compared with the 0.45% decline in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 10.53% as against Sensexs 5.90% decline.

The small-cap company has equity capital of Rs 12.59 crore. Face value per share is Rs 2.

Shares of Sunteck Realty rose 18.41% in four trading sessions to settle at Rs 227.65 yesterday, 13 December 2016, from its close of Rs 192.25 on 7 December 2016.

The stock surged 9.55% to Rs 227.65 yesterday, 13 December 2016, after the company reported robust Q2 earnings after market hours on Monday, 12 December 2016. Sunteck Realtys net profit surged 526.40% to Rs 97.28 crore on 582.32% rise in total income from operations to Rs 206.06 crore in Q2 September 2016 over Q2 September 2015.

Sunteck Realty (SRL) is a Mumbai‐based real estate development company, catering to the premium ultra‐luxury and luxury residential segment.

Powered by Capital Market - Live News

Royal Orchid Hotels advances after adding two more hotels
Dec 14,2016

The announcement was made after market hours yesterday, 13 December 2016.

Meanwhile, the BSE Sensex was down 48.55 points, or 0.18%, to 26,649.27.

On the BSE, 9,542 shares were traded in the counter so far as against average daily volume of 16,342 shares in the past one quarter. The stock had hit a high of Rs 77.65 and a low of Rs 74.60 so far during the day. The stock had hit a 52-week high of Rs 115.10 on 11 January 2016. The stock had hit a 52-week low of Rs 56.60 on 17 February 2016.

The stock had outperformed the market over the past 30 days till 13 December 2016, rising 1.52% compared with 0.45% decline in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 19.3% as against Sensexs 5.84% decline.

The small-cap company has equity capital of Rs 27.23 crore. Face value per share is Rs 10.

Royal Orchid Hotels announced the opening of two hotels under its brand Regenta Inn in Vadodara and Kolkata, which are slated to open on 15 December 2016, expanding count to 40 hotels by the end of 2016.

The brand Regenta Hotels is an upscale arm of the Royal Orchid Hotels group. It is categorized into Regenta, Regenta Central, Regenta Resorts and Regenta Inn.

Royal Orchid Hotels net profit rose 33.7% to Rs 2.74 crore on 8.7% decline in net sales to Rs 19.19 crore in Q2 September 2016 over Q2 September 2015.

Royal Orchid Hotels operates business and leisure hotels in popular destinations.

Powered by Capital Market - Live News

Lupin marches ahead after receiving final USFDA approval for generic ointment
Dec 14,2016

The announcement was made during market hours today, 14 December 2016.

Meanwhile, the BSE Sensex was down 26.61 points, or 0.1%, to 26,671.21.

On the BSE, 20,653 shares were traded on the counter so far as against the average daily volumes of 96,866 shares in the past one quarter. The stock had hit a high of Rs 1,509 and a low of Rs 1,482.40 so far during the day. The stock had hit a 52-week high of Rs 1,911.55 on 9 February 2016. The stock had hit a 52-week low of Rs 1,294.05 on 29 March 2016.

The stock had outperformed the market over the past 30 days till 13 December 2016, gaining 2.19% compared with 0.45% decline in the Sensex. The scrip had also outperformed the market in past one quarter, falling 2.67% as against Sensexs 5.84% decline.

The large-cap company has equity capital of Rs 90.27 crore. Face value per share is Rs 2.

Lupin announced that it has received final approval for its Desoximetasone Ointment USP, 0.05% from the United States Food & Drug Administration (USFDA) to market a generic version of Taro Pharms Norths Topicort Ointment, 0.05%. The product filing is from Lupins Pithampur, Indore manufacturing facility.

Lupins Desoximetasone Ointment USP, 0.05% is the AB rated generic equivalent of Taro Pharms Norths Topicort Ointment, 0.05%. It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Topicort Ointment had annual US sales of $12.1 million as per the IMS MAT September 2016 data.

Earlier this month, Lupin had received final approval for its Desoximetasone Ointment USP, 0.25% from US FDA to market a generic version of Taro Pharmaceuticals, Inc.s Topicort Ointment, 0.25% having annual US sales of $14.4 million as per the IMS MAT September 2016 data.

Lupins consolidated net profit jumped 57.8% to Rs 662.19 crore on 31.9% rise in net sales to Rs 4211.18 crore in Q2 September 2016 over Q2 September 2015.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Powered by Capital Market - Live News

Lupin marches ahead after receiving final USFDA approval for generic ointment
Dec 14,2016

The announcement was made during market hours today, 14 December 2016.

Meanwhile, the BSE Sensex was down 26.61 points, or 0.1%, to 26,671.21.

On the BSE, 20,653 shares were traded on the counter so far as against the average daily volumes of 96,866 shares in the past one quarter. The stock had hit a high of Rs 1,509 and a low of Rs 1,482.40 so far during the day. The stock had hit a 52-week high of Rs 1,911.55 on 9 February 2016. The stock had hit a 52-week low of Rs 1,294.05 on 29 March 2016.

The stock had outperformed the market over the past 30 days till 13 December 2016, gaining 2.19% compared with 0.45% decline in the Sensex. The scrip had also outperformed the market in past one quarter, falling 2.67% as against Sensexs 5.84% decline.

The large-cap company has equity capital of Rs 90.27 crore. Face value per share is Rs 2.

Lupin announced that it has received final approval for its Desoximetasone Ointment USP, 0.05% from the United States Food & Drug Administration (USFDA) to market a generic version of Taro Pharms Norths Topicort Ointment, 0.05%. The product filing is from Lupins Pithampur, Indore manufacturing facility.

Lupins Desoximetasone Ointment USP, 0.05% is the AB rated generic equivalent of Taro Pharms Norths Topicort Ointment, 0.05%. It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Topicort Ointment had annual US sales of $12.1 million as per the IMS MAT September 2016 data.

Earlier this month, Lupin had received final approval for its Desoximetasone Ointment USP, 0.25% from US FDA to market a generic version of Taro Pharmaceuticals, Inc.s Topicort Ointment, 0.25% having annual US sales of $14.4 million as per the IMS MAT September 2016 data.

Lupins consolidated net profit jumped 57.8% to Rs 662.19 crore on 31.9% rise in net sales to Rs 4211.18 crore in Q2 September 2016 over Q2 September 2015.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Powered by Capital Market - Live News

Kaveri Seeds Company leads losers in A group
Dec 14,2016

Kaveri Seeds Company slumped 6.09% to Rs 403 at 13:55 IST. The stock topped the losers in the BSEs A group. On the BSE, 3.58 lakh shares were traded on the counter so far as against the average daily volumes of 25,000 shares in the past two weeks.

Indiabulls Housing Finance slipped 3.66% at Rs 645.05. The stock was the second biggest loser in A group. On the BSE, 2.46 lakh shares were traded on the counter so far as against the average daily volumes of 49,000 shares in the past two weeks.

Coal India fell 3.57% to Rs 294.85 after consolidated net profit fell 77.37% to Rs 600.44 crore on 6.77% decline in total income to Rs 17625.09 crore in Q2 September 2016 over Q2 September 2015. The result was announced after market hours yesterday, 13 December 2016. The stock was the third biggest loser in A group. On the BSE, 4.63 lakh shares were traded on the counter so far as against the average daily volumes of 1.77 lakh shares in the past two weeks.

Amtek Auto declined 3.32% to Rs 36.40 after the company posted net loss of Rs 755.18 crore in Q2 September 2016 compared with net loss of Rs 158.62 crore in Q2 September 2015. The result was announced after market hours yesterday, 13 December 2016. The stock was the fourth biggest loser in A group. On the BSE, 2.46 lakh shares were traded on the counter so far as against the average daily volumes of 4.76 lakh shares in the past two weeks.

GMDC dropped 3.27% at Rs 97.75. The stock was the fifth biggest loser in A group. On the BSE, 1.08 lakh shares were traded on the counter so far as against the average daily volumes of 1.25 lakh shares in the past two weeks.

Powered by Capital Market - Live News

Kaveri Seeds Company leads losers in A group
Dec 14,2016

Kaveri Seeds Company slumped 6.09% to Rs 403 at 13:55 IST. The stock topped the losers in the BSEs A group. On the BSE, 3.58 lakh shares were traded on the counter so far as against the average daily volumes of 25,000 shares in the past two weeks.

Indiabulls Housing Finance slipped 3.66% at Rs 645.05. The stock was the second biggest loser in A group. On the BSE, 2.46 lakh shares were traded on the counter so far as against the average daily volumes of 49,000 shares in the past two weeks.

Coal India fell 3.57% to Rs 294.85 after consolidated net profit fell 77.37% to Rs 600.44 crore on 6.77% decline in total income to Rs 17625.09 crore in Q2 September 2016 over Q2 September 2015. The result was announced after market hours yesterday, 13 December 2016. The stock was the third biggest loser in A group. On the BSE, 4.63 lakh shares were traded on the counter so far as against the average daily volumes of 1.77 lakh shares in the past two weeks.

Amtek Auto declined 3.32% to Rs 36.40 after the company posted net loss of Rs 755.18 crore in Q2 September 2016 compared with net loss of Rs 158.62 crore in Q2 September 2015. The result was announced after market hours yesterday, 13 December 2016. The stock was the fourth biggest loser in A group. On the BSE, 2.46 lakh shares were traded on the counter so far as against the average daily volumes of 4.76 lakh shares in the past two weeks.

GMDC dropped 3.27% at Rs 97.75. The stock was the fifth biggest loser in A group. On the BSE, 1.08 lakh shares were traded on the counter so far as against the average daily volumes of 1.25 lakh shares in the past two weeks.

Powered by Capital Market - Live News